S&P 500

5.998,74

0,00%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Provectus Biopharmaceuticals Inc (QB) (PVCT)
Provectus Biopharmaceuticals Inc (QB) (PVCT) Notícias

PVCT

Provectus Biopharmaceuti... (QB) (PVCT)

Provectus Biopharmaceuticals Inc (QB)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:PVCT

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
25/11/2024	19:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
14/11/2024	10:00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
12/11/2024	17:34	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
14/08/2024	20:23	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
17/07/2024	17:07	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
20/06/2024	07:03	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
09/05/2024	11:54	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
06/05/2024	14:56	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
21/06/2023	10:46	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
16/06/2023	19:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
11/05/2023	16:19	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
11/05/2023	15:42	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
09/05/2023	17:53	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
01/05/2023	14:59	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
21/04/2023	15:43	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
28/03/2023	10:11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
12/12/2022	10:01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
28/10/2022	14:30	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
29/03/2022	17:05	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
25/11/2020	15:09	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
09/05/2019	17:50	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
21/04/2017	16:11	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
21/04/2017	14:58	Edgar (US Regulatory)	(25-NSE)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
20/04/2017	18:17	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
17/04/2017	18:18	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
30/03/2017	07:05	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
16/03/2017	17:17	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
06/03/2017	08:16	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
31/01/2017	09:23	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)
30/01/2017	09:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:PVCT	Provectus Biopharmaceuticals Inc (QB)